{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:24:14Z","timestamp":1789514654653,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00277-023-05119-3","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T13:05:13Z","timestamp":1676120713000},"page":"761-768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis"],"prefix":"10.1007","volume":"102","author":[{"given":"Marco","family":"Cerrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Raffoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Rabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"S\u00e9bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Valade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Itzykson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Lemiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Ad\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Boissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Dombret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0965-6615","authenticated-orcid":false,"given":"Etienne","family":"Lenglin\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,11]]},"reference":[{"key":"5119_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11912-019-0764-8","volume":"21","author":"M Cerrano","year":"2019","unstructured":"Cerrano M, Itzykson R (2019) New treatment options for acute myeloid leukemia in 2019. Curr Oncol Rep 21:16","journal-title":"Curr Oncol Rep"},{"key":"5119_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.16265","volume":"188","author":"\u00c5 Derolf","year":"2020","unstructured":"Derolf \u00c5, Juliusson G, Benson L, Fl\u00f8isand Y, Lazarevic V, Antunovic P et al (2020) Decreasing early mortality in acute myeloid leukaemia in Sweden 1997\u20132014: improving performance status is a major contributing factor. Br J Haematol 188:187\u2013191","journal-title":"Br J Haematol"},{"key":"5119_CR3","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.3109\/10428194.2014.887709","volume":"55","author":"A-S Moreau","year":"2014","unstructured":"Moreau A-S, Lengline E, Seguin A, Lemiale V, Canet E, Raffoux E et al (2014) Respiratory events at the earliest phase of acute myeloid leukemia. Leuk Lymphoma 55:2556\u20132563","journal-title":"Leuk Lymphoma"},{"key":"5119_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/bjh.12415","volume":"162","author":"M Darmon","year":"2013","unstructured":"Darmon M, Vincent F, Camous L, Canet E, Bonmati C, Braun T et al (2013) Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en R\u00e9animation Respiratoire et Onco-H\u00e9matologique. Br J Haematol 162:489\u2013497","journal-title":"Br J Haematol"},{"key":"5119_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.blre.2015.04.002","volume":"29","author":"E Azoulay","year":"2015","unstructured":"Azoulay E, P\u00e8ne F, Darmon M, Lenglin\u00e9 E, Benoit D, Soares M et al (2015) Managing critically Ill hematology patients: time to think differently. Blood Rev 29:359\u2013367","journal-title":"Blood Rev"},{"key":"5119_CR6","doi-asserted-by":"publisher","unstructured":"Canet E, Zafrani L, Lambert J, Thieblemont C, Galicier L, Schnell D et al (2013) Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PLoS One 8. https:\/\/doi.org\/10.1371\/journal.pone.0055870.","DOI":"10.1371\/journal.pone.0055870"},{"key":"5119_CR7","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/S0140-6736(10)62105-8","volume":"376","author":"U Krug","year":"2010","unstructured":"Krug U, R\u00f6llig C, Koschmieder A, Heinecke A, Sauerland MC, Schaich M et al (2010) Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes. Lancet 376:2000\u20132008","journal-title":"Lancet"},{"key":"5119_CR8","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1200\/JCO.2011.35.7525","volume":"29","author":"RB Walter","year":"2011","unstructured":"Walter RB, Othus M, Borthakur G, Ravandi F, Cortes JE, Pierce SA et al (2011) Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol 29:4417\u20134423","journal-title":"J Clin Oncol"},{"key":"5119_CR9","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1182\/blood-2014-10-551507","volume":"125","author":"C R\u00f6llig","year":"2015","unstructured":"R\u00f6llig C, Ehninger G (2015) How I treat hyperleukocytosis in acute myeloid leukemia. Blood 125:3246\u20133252","journal-title":"Blood"},{"key":"5119_CR10","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3109\/10428194.2011.649752","volume":"53","author":"E Lenglin\u00e9","year":"2012","unstructured":"Lenglin\u00e9 E, Raffoux E, Lemiale V, Darmon M, Canet E, Boissel N et al (2012) Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma 53:1352\u20131359","journal-title":"Leuk Lymphoma"},{"key":"5119_CR11","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.3109\/10428194.2016.1142083","volume":"57","author":"A-C Mamez","year":"2016","unstructured":"Mamez A-C, Raffoux E, Chevret S, Lemiale V, Boissel N, Canet E et al (2016) Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia. Leuk Lymphoma 57:2281\u20132288","journal-title":"Leuk Lymphoma"},{"key":"5119_CR12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.leukres.2014.01.004","volume":"38","author":"S Oberoi","year":"2014","unstructured":"Oberoi S, Lehrnbecher T, Phillips B, Hitzler J, Ethier M-C, Beyene J et al (2014) Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis. Leuk Res 38:460\u2013468","journal-title":"Leuk Res"},{"key":"5119_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/10428194.2019.1683735","volume":"61","author":"M Cerrano","year":"2020","unstructured":"Cerrano M, Seegers V, Raffoux E, Rabian F, S\u00e9bert M, Itzykson R et al (2020) Predictors and outcomes associated with hydroxyurea sensitivity in acute myeloid leukemia patients with high hyperleukocytosis. Leuk Lymphoma 61:737\u2013740","journal-title":"Leuk Lymphoma"},{"key":"5119_CR14","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1038\/s41375-020-0783-3","volume":"34","author":"M Stahl","year":"2020","unstructured":"Stahl M, Shallis RM, Wei W, Montesinos P, Lengline E, Neukirchen J et al (2020) Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study. Leukemia 34:3149\u20133160","journal-title":"Leukemia"},{"key":"5119_CR15","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","volume":"133","author":"MA Sanz","year":"2019","unstructured":"Sanz MA, Fenaux P, Tallman MS, Estey EH, L\u00f6wenberg B, Naoe T et al (2019) Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood 133:1630\u20131643","journal-title":"Blood"},{"key":"5119_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Recovery Collaborative Group et al (2021) Dexamethasone in hospitalized patients with COVID-19. N Engl J Med 384:693\u2013704","journal-title":"N Engl J Med"},{"key":"5119_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar J, Ferrando C, Mart\u00ednez D, Ambr\u00f3s A, Mu\u00f1oz T, Soler JA et al (2020) Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med 8:267\u2013276","journal-title":"Lancet Respir Med"},{"key":"5119_CR18","doi-asserted-by":"crossref","unstructured":"Fodil S, Arnaud M, Vaganay C, Puissant A, Lengline E, Mooney N, Itzykson R, Zafrani L (2022) Endothelial cells: major players in acute myeloid leukaemia. Blood Rev 54:100932","DOI":"10.1016\/j.blre.2022.100932"},{"key":"5119_CR19","doi-asserted-by":"publisher","first-page":"623952","DOI":"10.3389\/fonc.2021.623952","volume":"11","author":"C R\u00e9cher","year":"2021","unstructured":"R\u00e9cher C (2021) Clinical implications of inflammation in acute myeloid leukemia. Front Oncol 11:623952","journal-title":"Front Oncol"},{"key":"5119_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00057711","volume":"39","author":"\u00c9 Azoulay","year":"2012","unstructured":"Azoulay \u00c9, Canet E, Raffoux E, Lenglin\u00e9 E, Lemiale V, Vincent F et al (2012) Dexamethasone in patients with acute lung injury from acute monocytic leukaemia. Eur Respir J 39:648\u2013653","journal-title":"Eur Respir J"},{"key":"5119_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H D\u00f6hner","year":"2010","unstructured":"D\u00f6hner H, Estey EH, Amadori S, Appelbaum FR, B\u00fcchner T, Burnett AK et al (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115:453\u2013474","journal-title":"Blood"},{"key":"5119_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129:424\u2013447","journal-title":"Blood"},{"key":"5119_CR23","doi-asserted-by":"publisher","unstructured":"Bewersdorf JP, Zeidan AM. (2020) Hyperleukocytosis and leukostasis in acute myeloid leukemia: can a better understanding of the underlying molecular pathophysiology lead to novel treatments? Cells 9. https:\/\/doi.org\/10.3390\/cells9102310.","DOI":"10.3390\/cells9102310"},{"key":"5119_CR24","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3324\/haematol.2017.184267","volume":"103","author":"S Bertoli","year":"2018","unstructured":"Bertoli S, Picard M, B\u00e9rard E, Griessinger E, Larrue C, Mouchel PL et al (2018) Dexamethasone in hyperleukocytic acute myeloid leukemia. Haematologica 103:988\u2013998","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05119-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05119-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05119-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:36:36Z","timestamp":1744158996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05119-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,11]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["5119"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05119-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,11]]},"assertion":[{"value":"15 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}